Brunel University Research Archive(BURA) preserves and enables easy and open access to all
types of digital content. It showcases Brunel's research outputs.
Research contained within BURA is open access, although some publications may be subject
to publisher imposed embargoes. All awarded PhD theses are also archived on BURA.
Browsing by Author Karteris, E
Showing results 54 to 73 of 90
< previous
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 2023 | Investigation of the role of asprosin and downstream glycolytic molecules in ovarian cancer | Kerslake, Rachel |
| 2022 | Investigation the role of PARP inhibitors in ovarian cancer using in vitro models and clinical samples | Saravi, Sayeh |
| 3-Feb-2020 | Involvement of the Endocrine-Disrupting Chemical Bisphenol A (BPA) in Human Placentation | de Aguiar Greca, S-C; Kyrou, I; Pink, R; Randeva, H; Grammatopoulos, D; Silva, E; Karteris, E |
| 2018 | Involvement of the glutamine RF-amide peptide (QRFP) and its cognate receptor GPR103 in prostate cancer | Karteris, E; Kawan, M; Kyrou, I; Ramanjaneya, M; Williams, K; Jeyaneethi, J; Randeva, H |
| 14-Oct-2020 | Is there a link between bisphenol A (BPA), a key endocrine disruptor, and the risk for SARS-CoV-2 infection and severe COVID-19? | Zahra, A; Sisu, C; Silva, E; De Aguiar Greca, S-C; Randeva, H; Chatha, K; Kyrou, I; Karteris, E |
| 12-Sep-2019 | Kinase inhibitors and ovarian cancer | Katopodis, P; Chudasama, D; Wander, G; Sales, L; Kumar, J; Pandhal, M; Anikin, V; Chatterjee, J; Hall, M; Karteris, E |
| 21-Jan-2020 | Lack of association between screencell-detected circulating tumour cells and long-term survival of patients undergoing surgery for non-small cell lung cancer: A pilot clinical study | Barr, J; Chudasama, D; Rice, A; Karteris, E; Anikin, V |
| 7-Mar-2019 | Liquid biopsies in lung cancer: Four emerging technologies and potential clinical applications | Chudasama, D; Katopodis, P; Stone, N; Haskell, J; Sheridan, H; Gardner, B; Urnovitz, H; Schuetz, E; Beck, J; Hall, M; Barr, J; Sisu, C; Rice, A; Polychronis, A; Anikin, V; Karteris, E |
| 17-Jul-2023 | Malignant Mesothelioma subtyping via sampling driven multiple instance prediction on tissue image and cell morphology data | Eastwood, M; Marc, ST; Gao, X; Sailem, H; Offman, J; Karteris, E; Fernandez, AM; Jonigk, D; Cookson, W; Moffatt, M; Popat, S; Minhas, F; Robertus, JL |
| 23-Feb-2023 | MesoGraph: Automatic Profiling of Malignant Mesothelioma Subtypes from Histological Images | Eastwood, M; Sailem, H; Tudor, S; Gao, X; Offman, J; Karteris, E; Montero Fernandez, A; Jonigk, D; Cookson, W; Moffatt, M; Popat, S; Minhas, F; Lukas Robertus, J |
| 9-Oct-2023 | MesoGraph: Automatic profiling of mesothelioma subtypes from histological images | Eastwood, M; Sailem, H; Marc, ST; Gao, X; Offman, J; Karteris, E; Fernandez, AM; Jonigk, D; Cookson, W; Moffatt, M; Popat, S; Minhas, F; Robertus, JL |
| 8-Dec-2022 | A Meta-analysis of 2D vs. 3D Ovarian Cancer Cellular Models | Kerslake, R; Belay, B; Panfilov, S; Hall, M; Kyrou, I; Randeva, HS; Hyttinen, J; Karteris, E; Sisu, C |
| 2017 | Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells | Wagner, R; Stubiger, G; Veigel, D; Wuczkowski, M; Lanzerstorfer, P; Weghuber, J; Karteris, E; Nowikovsky, K; Wilfinger-Lutz, N; Singer, CF; Colomer, R; Benhamu, B; Lopez-Rodriguez, ML; Valent, P; Grunt, TW |
| 15-Sep-2020 | Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19 | Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Karteris, E; Kyrou, I |
| 18-Jan-2021 | Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19 | Kyrou, I; Randeva, HS; Spandidos, DA; Karteris, E |
| 28-Mar-2022 | NUCB2/Nesfatin-1 Reduces Obesogenic Diet Induced Inflammation in Mice Subcutaneous White Adipose Tissue | Gharanei, S; Ramanjaneya, M; Patel, AH; Patel, V; Shabir, K; Auld, C; Karteris, E; Kyrou, I; Randeva, HS |
| 30-Apr-2021 | On the role of artificial intelligence in medical imaging of COVID-19 | Born, J; Beymer, D; Rajan, D; Coy, A; Mukherjee, VV; Manica, M; Prasanna, P; Ballah, D; Guindy, M; Shaham, D; Shah, PL; Karteris, E; Robertus, JL; Gabrani, M; Rosen-Zvi, M |
| 2015 | Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103 | Davies, J; Chen, J; Pink, R; Carter, D; Saunders, N; Sotiriadis, G; Bai, B; Pan, Y; Howlett, D; Payne, A; Randeva, H; Karteris, E |
| 9-Jul-2021 | A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer | Kerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E |
| 26-May-2020 | Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19 | Katopodis, P; Anikin, V; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E |